Company Overview of Obio Pharmaceutical Holdings Limited
Obio Pharmaceutical Holdings Limited engages in the research, development, and commercialization of medicines for diseases and health issues in the areas of diabetes and influenza. The company is based in Tsimshatsui, Hong Kong. It has research and development facilities and operations in China and the United States. Obio Pharmaceutical Holdings Limited operates as a susbsidiary of Antiviral Technologies, Inc.
Unit 613, 6/F
West Wing Office Building
New World Centre
20 Salisbury Road
852 2317 1291
852 2721 5334
Key Executives for Obio Pharmaceutical Holdings Limited
Similar Private Companies By Industry
|Advance Pharmaceutical Co., Ltd.||Asia|
|Alphatech Bioengineering Limited||Asia|
|American Asia Pharmaceutical Investment Inc.||Asia|
|APC Pharmaceuticals & Chemical Ltd.||Asia|
|APTUS Therapeutics Limited||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Obio Pharmaceutical Holdings Limited, please visit www.obiopharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.